Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDKL5 Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02926898
What this trial is testing

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 87
Large-scale testing (Phase 3)UnknownNCT04611438
What this trial is testing

Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome

Who this might be right for
Dravet SyndromeLennox Gastaut Syndrome
Yonsei University 107
Not applicableEnded earlyNCT04537832
What this trial is testing

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 58
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Testing effectiveness (Phase 2)Study completedNCT02091206
What this trial is testing

A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04740476
What this trial is testing

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 60
Not applicableStudy completedNCT05982717
What this trial is testing

Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda 237
Not applicableNot Yet RecruitingNCT07801404
What this trial is testing

Biomarkers of Neurodegeneration, Synaptic Plasticity and Neuroinflammation in Dravet Syndrome

Who this might be right for
Dravet Syndrome (DS)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT06924827
What this trial is testing

Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Elizabeth Donner 25
Not applicableAvailableNCT04457687
What this trial is testing

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Who this might be right for
Epilepsies, MyoclonicDrug Resistant Epilepsy
Eisai Inc.
Not applicableApproved For MarketingNCT04437004
What this trial is testing

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Who this might be right for
Dravet Syndrome
University of California, Los Angeles
Not applicableWithdrawnNCT06395792
What this trial is testing

A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in Portugal

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda
Not applicableStudy completedNCT00299312
What this trial is testing

Genetic and Physical Characteristics of Rett Syndrome

Who this might be right for
Rett SyndromeMECP2 Duplication DisorderRett-related Disorder
University of Alabama at Birmingham 10
Not applicableStudy completedNCT03857451
What this trial is testing

Treatment of Gait Disorders in Children With Dravet Syndrome

Who this might be right for
Dravet SyndromeSevere Myoclonic Epilepsy of Infancy
Universiteit Antwerpen 50
Testing effectiveness (Phase 2)Ended earlyNCT03635073
What this trial is testing

Soticlestat in Adults and Children With Rare Epilepsies

Who this might be right for
EpilepsyDravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda 156
Not applicableLooking for participantsNCT05651204
What this trial is testing

GABA Biomarkers in Dravet Syndrome

Who this might be right for
Dravet Syndrome
Cook Children's Health Care System 36
Large-scale testing (Phase 3)Study completedNCT02224573
What this trial is testing

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
GW Research Ltd 681
Large-scale testing (Phase 3)Ended earlyNCT05560282
What this trial is testing

Fenfluramine for Adult Dravet Patients

Who this might be right for
Dravet SyndromeDravet Syndrome, Intractable
University Health Network, Toronto 7
Not applicableStudy completedNCT06447675
What this trial is testing

Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency Disorder
Xuanwu Hospital, Beijing 8
Not applicableUnknownNCT06504511
What this trial is testing

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

Who this might be right for
SCN1ADravet SyndromeEpilepsy
NHS Greater Glasgow and Clyde 400
Next Page